All Stories

  1. Unveiling the Roles of Cysteine Proteinases F and W: From Structure to Pathological Implications and Therapeutic Targets
  2. Swelling, Rupture and Endosomal Escape of Biological Nanoparticles Per Se and Those Fused with Liposomes in Acidic Environment
  3. Reprogramming Tumor-Associated Macrophage Using Nanocarriers: New Perspectives to Halt Cancer Progression
  4. Antiproliferative efficacy and mechanism of action of aggregation-resistant, polymorphous nanosilver functionalized with asparagus phytochemicals (Ar-AgNPs) in the breast adenocarcinoma MDA-MB-231 cells
  5. Physiologically based pharmacokinetic model for predicting the biodistribution of albumin nanoparticles after induction and recovery from acute lung injury
  6. Bioprospecting of Chlamydomonas reinhardtii for boosting biofuel-related products production based on novel aggregation-induced emission active extracellular polymeric substances nanoprobes
  7. The Intricate Balance between Life and Death: ROS, Cathepsins, and Their Interplay in Cell Death and Autophagy
  8. The menace of severe adverse events and deaths associated with viral gene therapy and its potential solution
  9. Clinical course and peculiarities of Parechovirus and Enterovirus central nervous system infections in newborns: a single-center experience
  10. Disruption of Cerebellar Granular Layer as a Consequence of Germinal Matrix Intraventricular Hemorrhage in Extreme Prematurity: An Acute Direct Mechanism Too?
  11. Early Extra-Uterine Growth Restriction in Very-Low-Birth-Weight Neonates with Normal or Mildly Abnormal Brain MRI: Effects on a 2–3-Year Neurodevelopmental Outcome
  12. Therapeutic and diagnostic applications of carbon nanotubes in cancer: recent advances and challenges
  13. Bioactive peptides: an alternative therapeutic approach for cancer management
  14. Early Extra-Uterine Growth Restriction in Very Low Birth Weight Neonates with Normal or Mildly Abnormal Brain MRI: Effects on 2–3 Years Neurodevelopmental Outcome
  15. The Importance of Nanocarriers’ Intra- and Extracellular Degradation: What we Know and Should Know About it?
  16. Single-Step Fabrication of Resonant Silicon–Gold Hybrid Nanoparticles for Efficient Optical Heating and Nanothermometry in Cells
  17. Expression, Intracellular Localization, and Maturation of Cysteine Cathepsins in Renal Embryonic and Cancer Cell Lines
  18. Smart Delivery Systems Responsive to Cathepsin B Activity for Cancer Treatment
  19. Proteolytic Resistance Determines Albumin Nanoparticle Drug Delivery Properties and Increases Cathepsin B, D, and G Expression
  20. Technological aspects of manufacturing and analytical control of biological nanoparticles
  21. Hydroxychloroquine Enhances Cytotoxic Properties of Extracellular Vesicles and Extracellular Vesicle–Mimetic Nanovesicles Loaded with Chemotherapeutics
  22. Surface topography of nanoplastics modulates their internalization and toxicity in liver cells
  23. Hydroxychloroquine Enhances Cytotoxic Properties of Extracellular Vesicles and Extracellular Vesicle-Mimetic Nanovesicles Loaded with Chemotherapeutics
  24. Cathepsin K in Pathological Conditions and New Therapeutic and Diagnostic Perspectives
  25. Anticancer Nanotherapeutics in Clinical Trials: The Work behind Clinical Translation of Nanomedicine
  26. Biomimetic approaches for targeting tumor-promoting inflammation
  27. Physiologically Based Pharmacokinetic Modeling of Nanoparticle Biodistribution: A Review of Existing Models, Simulation Software, and Data Analysis Tools
  28. New Advances in the Understanding of Proteases as Diagnostic and Pharmaceutical Targets in Homeostatic and Pathologic Conditions
  29. In Silico, In Vitro, and Clinical Investigations of Cathepsin B and Stefin A mRNA Expression and a Correlation Analysis in Kidney Cancer
  30. Nanomedicine for Treating Diabetic Retinopathy Vascular Degeneration
  31. Nanomedicine for increasing the oral bioavailability of cancer treatments
  32. Cathepsin D—Managing the Delicate Balance
  33. Long Non-Coding PROX1-AS1 Expression Correlates with Renal Cell Carcinoma Metastasis and Aggressiveness
  34. Endosomal Escape of Polymer‐Coated Silica Nanoparticles in Endothelial Cells
  35. Liposome-Embedding Silicon Microparticle for Oxaliplatin Delivery in Tumor Chemotherapy
  36. Smart Nanotheranostics Responsive to Pathological Stimuli
  37. Cysteine Cathepsins Inhibition Affects Their Expression and Human Renal Cancer Cell Phenotype
  38. Cellular Aging Characteristics and Their Association with Age-Related Disorders
  39. Biomimetic cellular vectors for enhancing drug delivery to the lungs
  40. The Role of Cysteine Cathepsins in Cancer Progression and Drug Resistance
  41. Albumin Nanovectors in Cancer Therapy and Imaging
  42. Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer
  43. Inflammation and Cancer: In Medio Stat Nano
  44. Trends towards Biomimicry in Theranostics
  45. Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery
  46. Ghee Butter as a Therapeutic Delivery System
  47. Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability
  48. Abstract 3910: Biomimetic proteo-lipid vesicles for the treatment of melanoma
  49. Effects of the protein corona on liposome–liposome and liposome–cell interactions
  50. Biomimetic proteolipid vesicles for targeting inflamed tissues
  51. One-pot synthesis of pH-responsive hybrid nanogel particles for the intracellular delivery of small interfering RNA
  52. Biologically Inspired Nanomaterials and Nanobiomagnetism: A Synergy among New Emerging Concepts in Regenerative Medicine
  53. Cell source determines the immunological impact of biomimetic nanoparticles
  54. Case Study: Application of LeukoLike Technology to Camouflage Nanoparticles from the Immune Recognition
  55. The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery
  56. Biomimetic interfaces to trigger tissue restoration
  57. Proteomic Profiling of a Biomimetic Drug Delivery Platform
  58. Abstract 4536: Biomimetic carriers modulate tumor vascular barrier function
  59. Enabling cytoplasmic delivery and organelle targeting by surface modification of nanocarriers
  60. Bromelain Surface Modification Increases the Diffusion of Silica Nanoparticles in the Tumor Extracellular Matrix
  61. Abstract 4586: The Leukosome: A biomimetic liposome for the targeting of inflamed tumor vasculature
  62. Electrophysiology and biochemical analysis of cyclocreatine uptake and effect in hippocampal slices
  63. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions
  64. Evaluation of Cell Function Upon Nanovector Internalization
  65. Encyclopedia of Nanotechnology
  66. Interactions of single-wall carbon nanotubes with endothelial cells
  67. A comparative study of leukaemia inhibitory factor and interleukin-1α intracellular content in a human keratinocyte cell line after exposure to cosmetic fragrances and sodium dodecyl sulphate
  68. Cytotoxic effect on human keratinocytes of crude extracts from planktonic Cnidaria
  69. Salvia somalensis essential oil as a potential cosmetic ingredient: solvent‐free microwave extraction, hydrodistillation, GC–MS analysis, odour evaluation and in vitro cytotoxicity assays
  70. Comparison of the irritation potentials of Boswellia serrata gum resin and of acetyl-11-keto-β-boswellic acid by in vitro cytotoxicity tests on human skin-derived cell lines
  71. 3,3,5‐Trimethylcyclohexanols and derived esters: green synthetic procedures, odour evaluation and in vitro skin cytotoxicity assays1
  72. The creatine transporter mediates the uptake of creatine by brain tissue, but not the uptake of two creatine-derived compounds
  73. Handbook of Immunological Properties of Engineered Nanomaterials